P29375 (KDM5A_HUMAN) Homo sapiens (Human)

Lysine-specific demethylase 5A UniProtKBInterProSTRINGInteractive Modelling

1690 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

46 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Solution structure of the PHD1 domain of histone demethylase KDM5A in complex with a histone H3(1-1… Heteromer
P68431;
287-344
ZN;
Assess
Crystal structure of JARID1A-PHD3 complexed with H3(1-9)K4me3 peptide Heteromer
Q92133;
1609-1659
ZN;
Assess
Crystal Structure of Jarid1a PHD finger bound to histone H3C4me3 peptide Heteromer
P68431;
1609-1659
ZN;
Assess
Crystal structure of KDM5A in complex with a naphthyridone inhibitorhomo-2-mer12-785
NI;ZN;6QN;
Assess
Crystal structure of pyrrolidine amide inhibitor [(3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidin-1-yl][…monomer12-785
NI;ZN;90S;SO4;
Assess
Crystal structure of selective pyrrolidine amide KDM5a inhibitor N-{(3R)-1-[3-(propan-2-yl)-1H-pyra…monomer12-785
NI;ZN;90V;
Assess
Structure of histone lysine demethylase KDM5A in complex with selective inhibitormonomer12-785
NI;ZN;50P;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethox…monomer11-588
DLJ;MN;EDO;DMS;GOL;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR GSK-J1monomer11-588
K0I;MN;GOL;SO4;DMS;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-N-(1-(3-isopropyl-1H-pyrazole-5-carbonyl)pyrroli…monomer11-588
MN;GOL;90V;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N49 i.e. 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2…monomer11-588
H6S;H6T;MN;DMS;SO4;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)…monomer11-588
DQG;MN;GOL;DMS;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(4,4-difluoropiperidin-1-yl)et…monomer11-588
DKS;MN;GOL;DMS;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(propoxy)methyl)-1H-pyrrolo[3,2-b…monomer11-588
DKP;MN;DMS;GOL;EDO;SO4;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N68 i.e. 2-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]i…monomer11-588
H61;MN;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(1-methyl-1H-imidazol-2-yl)eth…monomer11-588
DNV;MN;GOL;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N67 i.e. 2-(5-phenyl-4-(phenyl(2-(piperidin-1-yl)eth…monomer11-588
H6A;MN;GOL;DMS;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-N-(1-(3-isopropyl-1H-pyrazole-5-carbonyl)pyrroli…monomer11-588
DQJ;MN;DMS;GOL;EDO;
Assess
Linked KDM5A JMJ Domain Bound to the Covalent Inhibitor N69 i.e. [2-((3-acrylamidophenyl)(2-(piperi…monomer11-588
H74;MN;GOL;DMS;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N50 i.e. 2-(4-((2-(dimethylamino)ethyl)(ethyl)carbam…monomer11-588
H5Y;MN;DMS;GOL;SO4;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N8 ( 5-methyl-7-oxo-6-(propan-2-yl)-4,7-dihydropyraz…monomer11-588
6E8;MN;
Assess
LINKED KDM5A JMJ DOMAIN FORMING COVALENT BOND TO INHIBITOR N71 i.e. 2-((3-(4-(dimethylamino)but-2-e…monomer11-588
H77;HZV;HZM;MN;GOL;DMS;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE POTENTIAL HYDROLYSIS PRODUCT OF INHIBITOR N45 i.e. 3-((6-(4-(2…monomer11-588
H6M;MN;EDO;GOL;
Assess
Linked KDM5A JMJ Domain Bound to Inhibitor N70 i.e.[2-((3-aminophenyl)(2-(piperidin-1-yl)ethoxy)met…monomer11-588
H6V;MN;GOL;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)met…monomer11-588
DQG;MN;DMS;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)met…monomer11-588
DO1;MN;DMS;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 5-(1-(tert-butyl)-1H-pyrazol-4-yl)-6-isopropyl-7-oxo…monomer11-588
DQS;MN;EDO;GOL;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoe…monomer11-588
LQT;MN;
Assess
A High Resolution Structure of a Linked KDM5A Jmj Domain with Alpha-Ketoglutaratemonomer12-588
AKG;MN;GOL;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N16 [3-(2-(4-chlorophenyl)acetamido)isonicotinic aci…monomer12-588
6EO;MN;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N11 [3-({1-[2-(4,4-difluoropiperidin-1-yl)ethyl]-5-f…monomer12-588
6ED;MN;GOL;DMS;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N3 (4'-[(2-phenylethyl)carbamoyl][2,2'-bipyridine]-4…monomer12-588
6E7;MN;EDO;GOL;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N44 i.e. 3-((2-(pyridin-2-yl)-6-(4-(vinylsulfonyl)-1…monomer12-588
H6J;MN;GOL;DMS;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N19 [2-(5-((4-chloro-2-methylbenzyl)oxy)-1H-pyrazol-…monomer12-588
6EP;AKG;MN;EDO;GOL;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(3-(piperidin-1-yl)propoxy)methyl…monomer12-588
DNY;MN;EDO;GOL;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N10 8-(1-methyl-1H-imidazol-4-yl)-2-(4,4,4-trifluoro…monomer12-588
6EB;MN;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor C49 (2-{[(2-{[(E)-2-(dimethylamino)ethenyl](ethyl)am…monomer12-588
MMK;MN;GOL;EDO;
Assess
Linked KDM5A Jmj Domain Bound to the Inhibitor N12 [3-((1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)amin…monomer12-588
6EN;MN;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)((4,4-difluorocyclohexyl)methoxy)…monomer12-588
DKV;MN;GOL;EDO;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N53 i.e. 2-(5-([1,1'-biphenyl]-3-yl)-4-(1-(2-(piperi…monomer12-588
H67;MN;GOL;DMS;
Assess
A Linked Jumonji Domain of the KDM5A Lysine Demethylasemonomer12-588
MN;AKG;GOL;
Assess
LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N43 i.e. 3-((6-(4-acryloyl-1,4-diazepan-1-yl)-2-(pyr…monomer12-587
H6G;MN;
Assess
NMR structure of the ARID domain from the histone H3K4 demethylase RBP2monomer85-175
Assess
Solution structure of the PHD1 domain of histone demethylase KDM5Amonomer287-344
ZN;
Assess
Solution structure of JARID1A C-terminal PHD finger in complex with H3(1-9)K4me3monomer1609-1659
ZN;
Assess
Solution Structure of JARID1A C-terminal PHD fingermonomer1609-1659
ZN;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5k4l.1.Amonomer0.6612-785
NI;ZN;6QN;100.00
Assess
2e6r.1.Amonomer0.61292-363
ZN;65.28
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25k4l.1.Amonomer0.6512-785
NI;ZN;6QN;100.00
Assess
Isoform 22miq.1.Amonomer0.52281-349
ZN;60.87
Assess